Underexamined, women-led pattern and decoration movement explored in expansive exhibition
Installation image of With Pleasure: Pattern and Decoration in American Art 1972-1985, June 26 November 28, 2021. Hessel Museum of Art, Center for Curatorial Studies, Bard College, Annandale-onHudson, NY. Photo: Olympia Shannon.
ANNANDALE-ON-HUDSON, NY
.-The Hessel Museum of Art is presenting With Pleasure: Pattern and Decoration in American Art 19721985, the first full-scale scholarly North American survey of the groundbreaking yet understudied Pattern and Decoration art movement, originally on view at The Museum of Contemporary Art, Los Angeles (MOCA), from October 2019 to March 2020.
Spanning the years 1972 to 1985 and featuring 45 artists from across the United States, With Pleasure examines the Pattern and Decoration movements defiant embrace of forms traditionally coded as feminine, domestic, ornamental, or craft-based and thought to be categorically inferior to fine art. On v
7 JUNE 2021
A weight-loss drug described as a game-changer by obesity researchers has just been approved by the US Food and Drug Administration (FDA), representing the first time the agency has endorsed such a treatment in several years.
Wegovy, a weight-management therapy to be manufactured by Danish pharmaceutical company Novo Nordisk, is the the first FDA-approved weight-loss drug since 2014, but it s not entirely a new medication.
The same drug, called semaglutide, has been used in the US and other countries as an anti-diabetic medication for years. More recently, however, evidence has shown that semaglutide at a different dosage also functions as a powerful and effective appetite-suppressant.